Website stats for Clinuvel - clinuvel.com
CLINUVEL is a leader in the field of photomedicine, investigating the interaction of light and human biology and pioneering the concept of medicinal photoprotection – protecting skin from light. The concentration of resources and efforts on photomedicine has made CLINUVEL a leader in the field.
clinuvel.com was registered 1 decade 8 years ago. It has a alexa rank of #1,679,767 in the world. It is a domain having .com extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, clinuvel.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 522 |
| Daily Pageviews: | 1,044 |
Estimated Valuation
| Income Per Day: | $ 3.00 |
| Estimated Worth: | $ 720.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,679,767 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
64.207.159.230
Hosted Country:
US
Location Latitude:
39.0437Location Longitude:
-77.4875Traffic Classification
| Total Traffic: | Not Applicable |
| Direct Traffic: | Not Applicable |
| Referral Traffic: | Not Applicable |
| Search Traffic: | Not Applicable |
| Social Traffic: | Not Applicable |
| Mail Traffic: | Not Applicable |
| Display Traffic: | Not Applicable |
Search Engine Results For clinuvel.com
CLINUVEL to Trial Innovative Drug in Stroke - GlobeNewswire
Oct 27, 2020 ... CLINUVEL's lead compound, SCENESSE® (afamelanotide 16mg), was approved by the European Commission in 2014 and the US Food and ...
Clinuvel Pharmaceuticals - Crunchbase Company Profile & Funding
Clinuvel Pharmaceuticals is a global bio pharmaceutical developing drugs for severe skin disorder.
CLINUVEL CONFIRMS AGM DATE - Open Briefing
Sep 23, 2020 ... CLINUVEL PHARMACEUTICALS LTD today announces it will hold its 2020 Annual General Meeting (AGM) of shareholders on Wednesday 11 ...
CLINUVEL expands DNA Repair Program | BioSpace
Mar 23, 2021 ... CLINUVEL expands DNA Repair Program - read this article along with other careers information, tips and advice on BioSpace.
SCENESSE® Savings Program - SCENESSE® (Afamelanotide)
CLINUVEL is committed to facilitating treatment access for eligible patients with a confirmed diagnosis of erythropoietic protoporphyria (EPP). Savings may be ...
CLINUVEL Company Profile - Office Locations, Competitors ...
CLINUVEL PHARMACEUTICALS is a company that provides drugs for the treatment of severe skin disorders. It develops SCENESSE, a compound targeting ...
Clinuvel Pharmaceuticals Ltd Email Format | clinuvel.com Emails
Clinuvel Pharmaceuticals Ltd uses 2 email formats: 1. first '.' [email protected] ( 91.9%). Enter a name to find & verify an email >>>
Clinuvel Pharmaceuticals Ltd SEC Registration - SEC Report
Security and exchange commission filings for Clinuvel Pharmaceuticals Ltd. Insider trades, quarterly, and annual reports.
Get shorty: how Clinuvel Pharmaceuticals beat the hedgies ...
Apr 16, 2021 ... The acrimonious battle between hedge fund short-sellers and Australian biopharma group Clinuvel Pharmaceuticals appears finally to be ...
Clinuvel (UK) Limited - BIA
Clinuvel Pharmaceuticals is a global biopharmaceutical company focused on developing and delivering treatments for patients with a range of severe genetic ...
Welcome to CLINUVEL - CLINUVEL Group
The CLINUVEL Group ... We are a global biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, ...
SCENESSE® for Erythropoietic Protoporphyria – Getting Started ...
Clinuvel will email you within 48 hours with a request for documentation to obtain an individual unique identifier number (ID). The requested documentation will ...
CLINUVEL PHARMACEUTICALS LTD - Overview, Competitors, and ...
CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY; XETRA-DAX: UR9) is a global and diversified ...
View Study - ENCePP
Jun 23, 2020 ... Pharmaceutical companiesClinuvel100. Charities. Government body ... number ( incl. country code). Email address [email protected] ...
Clinuvel Pharmaceuticals Limited | Company Summary | ASX:CUV ...
Clinuvel Pharmaceuticals Limited (ASX:CUV) is a leading and innovative Australian company focused on the development of afamelanotide, its proprietary ...
Clinuvel's Competitors, Revenue, Number of Employees, Funding ...
Clinuvel is a biopharmaceutical company that develops and commercializes drugs for the treatment of skin disorders. Read more. Willem Blijdorp's photo - CEO of ...
CUV | Clinuvel Pharmaceuticals Stock Price - StockLight
Clinuvel Pharmaceuticals Ltd. is a leading and innovative Australian company focused on the development of SCENESSE¿ (afamelanotide), its proprietary ...
Clinuvel Pharmaceuticals Limited (CLVLY) Stock Price Today ...
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering drugs for the treatment of patients with severe genetic ...
Clinuvel Pharmaceuticals | The Org
Clinuvel Pharmaceuticals is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with ...
Clinuvel Pharmaceuticals Limited (ASX: CUV) - Yumpu
Clinuvel Pharmaceuticals Limited (ASX: CUV). Clinuvel is an Australian biopharmaceutical company focused on developing its leading photoprotective drug.
Clinuvel: Structural changes in preparation for commercial phase ...
Jun 29, 2010 ... Melbourne, Australia - Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA- DAX: UR9; ADR: CLVLY) today announced changes to its ...
CLVLF: Clinuvel Pharmaceuticals Ltd - Stock Price, Quote and News ...
Get Clinuvel Pharmaceuticals Ltd (CLVLF:OTCPK) real-time stock quotes, news, price and financial information from CNBC.
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | Not Applicable |
| H3 Headings: | 15 | H4 Headings: | Not Applicable |
| H5 Headings: | 4 | H6 Headings: | 5 |
| Total IFRAMEs: | Not Applicable | Total Images: | 22 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-4817934-6 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Read More | 8 | 1.421 % | No |
| CLINUVEL June | 6 | 1.066 % | No |
| Posted by | 6 | 1.066 % | No |
| min read | 6 | 1.066 % | No |
| by CLINUVEL | 6 | 1.066 % | No |
| 2021 2021 | 5 | 0.888 % | No |
| 2021 Announcements | 5 | 0.888 % | No |
| More Posted | 5 | 0.888 % | No |
| DNA Repair | 4 | 0.71 % | No |
| read CLINUVEL | 3 | 0.533 % | No |
| is a | 3 | 0.533 % | No |
| Privacy Policy | 2 | 0.355 % | No |
| Disclaimer Privacy | 2 | 0.355 % | No |
| Sitemap Disclaimer | 2 | 0.355 % | No |
| afamelanotide Read | 2 | 0.355 % | No |
| stroke patient | 2 | 0.355 % | No |
| patient treated | 2 | 0.355 % | No |
| treated with | 2 | 0.355 % | No |
| reserved Sitemap | 2 | 0.355 % | No |
| 6 min | 2 | 0.355 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Posted by CLINUVEL June | 6 | 1.066 % | No |
| More Posted by CLINUVEL | 5 | 0.888 % | No |
| Read More Posted by | 5 | 0.888 % | No |
| the concept of medicinal | 2 | 0.355 % | No |
| by CLINUVEL June 7 | 2 | 0.355 % | No |
| 7 2021 2021 Announcements | 2 | 0.355 % | No |
| PHARMACEUTICALS LTD 2020 All | 2 | 0.355 % | No |
| LTD 2020 All right | 2 | 0.355 % | No |
| June 7 2021 2021 | 2 | 0.355 % | No |
| 2020 All right reserved | 2 | 0.355 % | No |
| Sitemap Disclaimer Privacy Policy | 2 | 0.355 % | No |
| 2021 2021 Announcements Newsletter | 2 | 0.355 % | No |
| concept of medicinal photoprotection | 2 | 0.355 % | No |
| reserved Sitemap Disclaimer Privacy | 2 | 0.355 % | No |
| right reserved Sitemap Disclaimer | 2 | 0.355 % | No |
| CLINUVEL PHARMACEUTICALS LTD 2020 | 2 | 0.355 % | No |
| All right reserved Sitemap | 2 | 0.355 % | No |
| III Read More Posted | 2 | 0.355 % | No |
| CLINUVEL June 7 2021 | 2 | 0.355 % | No |
| – Fb Tw Li | 2 | 0.355 % | No |
Mobile Friendly Check
Mobile Friendly : Unknown
Score : Unknown
No data to show.
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Server: Sucuri/Cloudproxy
Date: Sat, 19 Jun 2021 11:07:20 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
X-Sucuri-ID: 15006
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
X-Content-Type-Options: nosniff
Content-Security-Policy: upgrade-insecure-requests;
Link:
Vary: Accept-Encoding,User-Agent
Content-Encoding: gzip
X-Sucuri-Cache: MISS
Domain Information
| Domain Registrar: |
CSC Corporate Domains, Inc.
|
|---|---|
| Registration Date: | 2006-01-10 1 decade 8 years 5 months ago |
| Last Modified: | 2021-01-06 3 years 5 months 3 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.mediatemple.net | |
97.74.100.1 | United States |
| ns2.mediatemple.net | |
173.201.68.1 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| clinuvel.com | A | 293 |
IP: 192.124.249.106 |
| clinuvel.com | A | 293 |
IP: 64.207.159.230 |
| clinuvel.com | NS | 300 |
Target: ns1.mediatemple.net |
| clinuvel.com | NS | 300 |
Target: ns2.mediatemple.net |
| clinuvel.com | SOA | 300 |
MNAME: ns1.mediatemple.net RNAME: dnsadmin.mediatemple.net Serial: 2021060901 Refresh: 10800 Retry: 3600 Expire: 1209600 |
| clinuvel.com | MX | 300 |
Priority: 10 Target: clinuvel-com-tls10.mxthunder.com |
| clinuvel.com | MX | 300 |
Priority: 40 Target: clinuvel-com-tls40.mxthunder.com |
| clinuvel.com | MX | 300 |
Priority: 20 Target: clinuvel-com-tls20.mxthunder.com |
| clinuvel.com | MX | 300 |
Priority: 30 Target: clinuvel-com-tls30.mxthunder.com |
| clinuvel.com | TXT | 300 |
TXT: hi6s3sv9dmnbe9tqsj3nq5hpe4 |
| clinuvel.com | TXT | 300 |
TXT: v=spf1 a mx ip4:64.207.159.230 ip4:195.144.18.204 ip4:195.144.18.76 ip4:195.144.18.230 ip4:195.144.18.231 ip4:14.201.63.210 ip4:14.203.101.166 include:spf.spamhero.com include:spf.protection.outlook.com include:sendgrid.net -all |
| clinuvel.com | TXT | 300 |
TXT: google-site-verification=8V9vt58b-FkBqXT DcLvggDRuSG_e1NeCVVHts_ZuK1o |
| clinuvel.com | TXT | 300 |
TXT: MS=ms40870313 |
| clinuvel.com | TXT | 300 |
TXT: jg7a1uf7ennr2vj6aj836b1sml |
| clinuvel.com | TXT | 300 |
TXT: notokenfound |
Alexa Traffic Rank
Alexa Search Engine Traffic
Full WHOIS Lookup
Registry Domain ID:
311485899_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.corporatedomains.com
Registrar URL:
http://cscdbs.com
Updated Date: 2021-01-06T06:22:42Z
Creation
Date: 2006-01-10T00:42:54Z
Registry Expiry Date:
2022-01-10T00:42:54Z
Registrar: CSC Corporate Domains,
Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
8887802723
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS1.MEDIATEMPLE.NET
Name Server: NS2.MEDIATEMPLE.NET
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2021-06-19T11:07:09Z
Similarly Ranked Websites
Africa Solution Distibutor | Your Preferred Network and Cloud...
ASD distributor of IT Network Products in Africa
1,679,768 
$ 720.00
Meuble design et mobilier pas cher - Miliboo
La livraison est gratuite sur tout le site! A la recherche de meubles design ? Découvrez les coups de coeur mobilier de notre ambassadeur Stéphane Plaza.
1,679,787 $ 720.00
Web Design Bentonville | Web Design Northwest Arkansas
Simplemachine offers web design services in Northwest Arkansas including web design in Bentonville, Rogers, Bella Vista, Fayetteville & Springdale Arkansas.
1,679,790 $ 720.00